pubmed-article:1904630 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:1904630 | lifeskim:mentions | umls-concept:C0007634 | lld:lifeskim |
pubmed-article:1904630 | lifeskim:mentions | umls-concept:C0010453 | lld:lifeskim |
pubmed-article:1904630 | lifeskim:mentions | umls-concept:C0596997 | lld:lifeskim |
pubmed-article:1904630 | lifeskim:mentions | umls-concept:C0005516 | lld:lifeskim |
pubmed-article:1904630 | lifeskim:mentions | umls-concept:C0017262 | lld:lifeskim |
pubmed-article:1904630 | lifeskim:mentions | umls-concept:C1413044 | lld:lifeskim |
pubmed-article:1904630 | lifeskim:mentions | umls-concept:C0936012 | lld:lifeskim |
pubmed-article:1904630 | lifeskim:mentions | umls-concept:C2911684 | lld:lifeskim |
pubmed-article:1904630 | lifeskim:mentions | umls-concept:C0185117 | lld:lifeskim |
pubmed-article:1904630 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:1904630 | pubmed:dateCreated | 1991-7-17 | lld:pubmed |
pubmed-article:1904630 | pubmed:abstractText | Carbonic anhydrase III (CAIII) is an abundant muscle protein characteristic of adult type-1, slow-twitch, muscle fibers. We demonstrate that CAIII is not confined to mature muscle but is also expressed in cultured myogenic cells that were originally derived from adult and fetal limb muscle (G8 and C2C12) and by azacytidine treatment of 10T1/2 fibroblasts (23A2). Transcripts may accumulate in these cells to levels that correspond to 6.5% of that found in mature muscle. CAIII is expressed in mononucleate myoblasts and is abundant in those that preferentially fuse to form myotubes, and these findings contrast with those for many other muscle genes whose transcripts only accumulate on or after terminal differentiation. Preliminary promoter-function assays by transfection shows that 2.8 kb of sequence flanking the 5' end of the human CAIII gene efficiently promotes transcription of the bacterial chloramphenicol acetyltransferase gene in myogenic cells. However, none of the sequences within this region are sufficient to confer muscle-specific expression. Removal of sequences 5' to -715 bp leads to a major loss of transcriptional activity of the CAIII promoter. These results imply that the proximal CAIII promoter, which includes a putative CArG box and four potential MyoD binding sites, is not adequate for either myoblast-specific or maximal transcription. | lld:pubmed |
pubmed-article:1904630 | pubmed:language | eng | lld:pubmed |
pubmed-article:1904630 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1904630 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:1904630 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1904630 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1904630 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1904630 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1904630 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1904630 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:1904630 | pubmed:month | May | lld:pubmed |
pubmed-article:1904630 | pubmed:issn | 0740-7750 | lld:pubmed |
pubmed-article:1904630 | pubmed:author | pubmed-author:EdwardsY HYH | lld:pubmed |
pubmed-article:1904630 | pubmed:author | pubmed-author:MorrisonKK | lld:pubmed |
pubmed-article:1904630 | pubmed:author | pubmed-author:CharltonJJ | lld:pubmed |
pubmed-article:1904630 | pubmed:author | pubmed-author:TweedieSS | lld:pubmed |
pubmed-article:1904630 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:1904630 | pubmed:volume | 17 | lld:pubmed |
pubmed-article:1904630 | pubmed:geneSymbol | CAIII | lld:pubmed |
pubmed-article:1904630 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:1904630 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:1904630 | pubmed:pagination | 215-28 | lld:pubmed |
pubmed-article:1904630 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
pubmed-article:1904630 | pubmed:meshHeading | pubmed-meshheading:1904630-... | lld:pubmed |
pubmed-article:1904630 | pubmed:meshHeading | pubmed-meshheading:1904630-... | lld:pubmed |
pubmed-article:1904630 | pubmed:meshHeading | pubmed-meshheading:1904630-... | lld:pubmed |
pubmed-article:1904630 | pubmed:meshHeading | pubmed-meshheading:1904630-... | lld:pubmed |
pubmed-article:1904630 | pubmed:meshHeading | pubmed-meshheading:1904630-... | lld:pubmed |
pubmed-article:1904630 | pubmed:meshHeading | pubmed-meshheading:1904630-... | lld:pubmed |
pubmed-article:1904630 | pubmed:meshHeading | pubmed-meshheading:1904630-... | lld:pubmed |
pubmed-article:1904630 | pubmed:meshHeading | pubmed-meshheading:1904630-... | lld:pubmed |
pubmed-article:1904630 | pubmed:meshHeading | pubmed-meshheading:1904630-... | lld:pubmed |
pubmed-article:1904630 | pubmed:meshHeading | pubmed-meshheading:1904630-... | lld:pubmed |
pubmed-article:1904630 | pubmed:meshHeading | pubmed-meshheading:1904630-... | lld:pubmed |
pubmed-article:1904630 | pubmed:meshHeading | pubmed-meshheading:1904630-... | lld:pubmed |
pubmed-article:1904630 | pubmed:meshHeading | pubmed-meshheading:1904630-... | lld:pubmed |
pubmed-article:1904630 | pubmed:meshHeading | pubmed-meshheading:1904630-... | lld:pubmed |
pubmed-article:1904630 | pubmed:meshHeading | pubmed-meshheading:1904630-... | lld:pubmed |
pubmed-article:1904630 | pubmed:meshHeading | pubmed-meshheading:1904630-... | lld:pubmed |
pubmed-article:1904630 | pubmed:meshHeading | pubmed-meshheading:1904630-... | lld:pubmed |
pubmed-article:1904630 | pubmed:meshHeading | pubmed-meshheading:1904630-... | lld:pubmed |
pubmed-article:1904630 | pubmed:year | 1991 | lld:pubmed |
pubmed-article:1904630 | pubmed:articleTitle | CAIII a marker for early myogenesis: analysis of expression in cultured myogenic cells. | lld:pubmed |
pubmed-article:1904630 | pubmed:affiliation | MRC Human Biochemical Genetics Unit, Galton Laboratory, London, U.K. | lld:pubmed |
pubmed-article:1904630 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:1904630 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |